Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice

BACKGROUND: Alzheimer’s disease is widely described since the discovery of histopathological lesions in Mrs. Auguste Deter in 1906. However to date, there is no effective treatment to deal with the many cellular and molecular alterations. The complexity is even higher with the growing evidence of in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vérité, J., Janet, T., Chassaing, D., Fauconneau, B., Rabeony, H., Page, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001165/
https://www.ncbi.nlm.nih.gov/pubmed/29898739
http://dx.doi.org/10.1186/s12974-018-1220-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001165/
https://www.ncbi.nlm.nih.gov/pubmed/29898739
http://dx.doi.org/10.1186/s12974-018-1220-7

Ejemplares similares